<DOC>
	<DOCNO>NCT01474213</DOCNO>
	<brief_summary>The purpose study compare sedation effect dexmedetomidine target control remifentanil awake nasotracheal fibreoptic intubation patient undergoing oral maxillofacial surgery .</brief_summary>
	<brief_title>Sedation Effect Dexmedetomidine Versus Remifentanil Fibreoptic Intubation</brief_title>
	<detailed_description>Awake fibreoptic nasotracheal intubation effective technique management patient difficult airway undergo oral maxillofacial surgery . Both optimal intubating condition patient comfort paramount prepare patient fibreoptic intubation . One challenge associate procedure provide adequate sedation maintain patient ' airway ventilation . Dexmedetomidine , sedative , analgesic property minimal influence patient ' ventilation , might useful management . While development target control infusion ( TCI ) technology , remifentanil sedation become potential sedation clinical practice .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>ASA grade IIII adult patient difficult airway , undergo elective oral maxillofacial surgery pregnant lactate female , longterm opioids sedative medication , patient &lt; 18 year age , severe bradycardia ( HR &lt; 50 beats/min ) , hypotension ( systolic pressure &lt; 90mmHg ) , type atrioventricular block ECG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>dexmedetomidine</keyword>
	<keyword>remifentanil</keyword>
	<keyword>awake nasotracheal fibreoptic intubation</keyword>
	<keyword>oral maxillofacial surgery</keyword>
	<keyword>difficult airway</keyword>
	<keyword>adult</keyword>
</DOC>